DaVita Inc. $DVA Stock Holdings Boosted by Wellington Management Group LLP

Key Points

• Wellington Management Group LLP increased its stake in DaVita Inc. by 207.9%, acquiring an additional 5,637 shares, bringing its total holdings to 8,348 shares valued at approximately $1.28 million.
• DaVita reported earnings of $2.95 per share for the last quarter, surpassing analysts' estimates of $2.70, with a revenue of $3.38 billion, up 6.1% year-over-year.
• Several analysts have adjusted their price targets for DaVita, with Truist Financial setting a new target price of $148, while Barclays lowered their target from $169 to $160, maintaining an "equal weight" rating.

Wellington Management Group LLP grew its position in shares of DaVita Inc. (NYSE:DVA - Free Report) by 207.9% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,348 shares of the company's stock after purchasing an additional 5,637 shares during the period. Wellington Management Group LLP's holdings in DaVita were worth $1,277,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. UMB Bank n.a. grew its holdings in DaVita by 65.5% during the 1st quarter. UMB Bank n.a. now owns 192 shares of the company's stock valued at $29,000 after purchasing an additional 76 shares in the last quarter. National Pension Service boosted its position in DaVita by 74.3% in the 1st quarter. National Pension Service now owns 197 shares of the company's stock valued at $30,000 after buying an additional 84 shares during the last quarter. Copia Wealth Management acquired a new stake in shares of DaVita during the fourth quarter valued at about $30,000. Y.D. More Investments Ltd purchased a new stake in shares of DaVita during the first quarter worth about $35,000. Finally, University of Texas Texas AM Investment Management Co. acquired a new position in shares of DaVita in the first quarter worth about $83,000. 90.12% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on DVA shares. Barclays lowered their price objective on DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a research note on Thursday, August 7th. Truist Financial set a $148.00 target price on DaVita in a research note on Friday, August 8th. Finally, Wall Street Zen upgraded shares of DaVita from a "hold" rating to a "buy" rating in a research note on Friday, August 22nd. Three analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $164.00.

DaVita Price Performance

Shares of NYSE:DVA remained flat at $135.97 on Thursday. 359,989 shares of the company's stock were exchanged, compared to its average volume of 852,625. The business has a fifty day simple moving average of $139.59 and a 200-day simple moving average of $142.20. The company has a debt-to-equity ratio of 23.18, a current ratio of 1.39 and a quick ratio of 1.34. DaVita Inc. has a 52 week low of $126.07 and a 52 week high of $179.60. The company has a market cap of $9.72 billion, a price-to-earnings ratio of 13.36, a price-to-earnings-growth ratio of 0.99 and a beta of 1.13.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $2.95 EPS for the quarter, beating the consensus estimate of $2.70 by $0.25. The business had revenue of $3.38 billion during the quarter, compared to analyst estimates of $3.36 billion. DaVita had a net margin of 6.35% and a return on equity of 369.39%. The company's quarterly revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the business posted $2.00 EPS. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. Analysts predict that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

Insider Activity at DaVita

In other news, insider James O. Hearty sold 2,351 shares of the company's stock in a transaction that occurred on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total transaction of $352,650.00. Following the completion of the transaction, the insider directly owned 26,038 shares of the company's stock, valued at approximately $3,905,700. This represents a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 1.50% of the company's stock.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.